Immune Management ApS: Financial statements 2018
CVR: 38726137
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Immune Management ApS (CVR 38726137) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 500,123 and a net result of DKK -55,292 compared with DKK 111,372 the year before. That is a decrease of 38.9% compared with the year before. Equity in the 2018 report amounted to DKK 302,760. The solvency ratio was 69.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 500,123
- Profit/Loss
- DKK -55,292
- Equity
- DKK 302,760
- Total Assets
- DKK 434,436
- Employees
- 1
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Immune Management ApS has published its annual report for 2017. Gross profit came to DKK 818,378, and the net result was DKK 111,372.
About Immune Management ApS
Immune Management ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2017. The company has been dissolved on 2 December 2024. The company was registered under the industry Virksomhedsrådgivning og anden rådgivning om driftsledelse. The company has 1 employee (2018). In 2023, the company reported a gross profit of DKK -13,493 and a net result of DKK -15,195 compared with DKK -16,738 the year before. Equity in the 2023 report amounted to DKK 41,224.